Plain-English translation of NCT07406945 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new device called the SpydrBlade Flex, which is used during a minimally invasive throat procedure to treat achalasia—a condition where your lower esophageal sphincter (the muscle that controls food entering your stomach) doesn't relax properly. The procedure, called per-oral endoscopic myotomy or POEM, involves creating a small tunnel in your esophagus and carefully cutting the muscle to help food pass through. Researchers want to confirm that this new tool is both safe and effective for patients like you.
Achalasia causes progressive difficulty swallowing and can significantly impact quality of life, but many patients are misdiagnosed or face delayed treatment. While POEM is already a successful minimally invasive option, this trial exists to evaluate whether this novel flexible device improves the procedure's safety and outcomes.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will receive the POEM procedure performed with the new SpydrBlade Flex device under general anesthesia at one of the participating medical centers. The procedure itself involves an endoscope (a thin camera) passed through your mouth to reach your esophagus, where the surgeon will create a small tunnel in the esophageal lining and cut the sphincter muscle to improve swallowing. Your doctors will monitor your symptoms and recovery using standardized symptom scores before and after the procedure to measure how well the treatment worked.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
Ecuador
Hong Kong